Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Training Experience

McGill University

$300,000.00

Programmed Molecules for Therapeutics, Sensing and Diagnostics (PROMOTE)

EF 2022-23

Résumé
aptamers and switches; biometerials; diagnostics; dna and rna; dna nanotechnology; drug delivery; imaging; nucleic acids; oligonucleotide therapeutics; tissue regeneration
Programme
Collaborative Research and Training Experience
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
528279-2019
Name nom
Sleiman, Hanadi HFS
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2019
Award amount
300000
Program id
CREAT
Program name en
Collaborative Research and Training Experience
Program name fr
Programme de formation orientée vers la nouveauté, la collaboration et l'expérience en recherche
Group en
RESEARCH TRAINING AND TALENT DEVELOPMENT
Group fr
FORMATION EN RECHERCHE ET PERFECTIONNEMENT DES COM
Committee code
1078
Committee name en
CREATE Program
Committee name fr
Programme FONCER
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Installment
inst:5
Partie
1
Nb partie
5
Application title
Programmed Molecules for Therapeutics, Sensing and Diagnostics (PROMOTE)
Application summary
aptamers and switches; biometerials; diagnostics; dna and rna; dna nanotechnology; drug delivery; imaging; nucleic acids; oligonucleotide therapeutics; tissue regeneration